New study links atopic dermatitis with vitiligo Medha Baranwal Baranwal5 Jan 2020 7:15 PM ISTNepal: Results from a recent review have supported an association between atopic dermatitis (AD) and vitiligo.The study, published in the Journal of...
Atopic dermatitis patients at higher risk of osteoporosis Medha Baranwal Baranwal2 Jan 2020 7:28 PM ISTAbsolute risk is low, but it's real -- People with atopic dermatitis (AD) are at a significantly higher risk of osteoporosis and major osteoporotic...
Eczema patients at increased risk of osteoporotic fractures, finds study Medha Baranwal Baranwal22 Nov 2019 7:28 PM ISTUK: Eczema patients are at increased risk of fracture specifically major osteoporotic fractures. finds a recent study published in the Journal of...
Tips for treating Atopic dermatitis in children by American Academy of Dermatology Dr. Kamal Kant Kohli Kohli13 Oct 2019 7:01 PM ISTIn the Eczema Awareness Month dermatologists of American Academy of Dermatology have released Tips for treating Atopic dermatitis in children.Atopic...
Long-term safety and efficacy of dupilumab in atopic dermatitis confirmed in two studies Dr. Kamal Kant Kohli Kohli10 Oct 2019 7:15 PM ISTResults of two studies have demonstrated the long term safety and efficacy of dupilumab in atopic dermatitis. The results of these latest studies have...
Atopic dermatitis patients are at increased long-term risk for AF Medha Baranwal Baranwal18 Sept 2019 7:15 PM ISTDelhi: Patients with moderate to severe atopic dermatitis have a 20% increased long-term risk of atrial fibrillation, according to a 35 year-long...
Cyclosporine quick and reliable treatment for atopic dermatitis in kids Medha Baranwal Baranwal3 Sept 2019 7:10 PM ISTDelhi: Cyclosporine should be considered as the systemic treatment of choice for children and adolescents with severe refractory atopic dermatitis,...
Baricitinib effective for treating moderate to severe atopic dermatitis, reveal clinical trial results Medha Baranwal Baranwal2 Sept 2019 7:30 PM ISTBaricitinib, an oral JAK inhibitor, has met its primary endpoint for the treatment of moderate to severe atopic dermatitis (AD) in adults, in...
